Literature DB >> 20974824

Myeloperoxidase selectively binds and selectively kills microbes.

Robert C Allen1, Jackson T Stephens.   

Abstract

Myeloperoxidase (MPO) is reported to selectively bind to bacteria. The present study provides direct evidence of MPO binding selectivity and tests the relationship of selective binding to selective killing. The microbicidal effectiveness of H(2)O(2) and of OCl(-) was compared to that of MPO plus H(2)O(2). Synergistic microbicidal action was investigated by combining Streptococcus sanguinis, a H(2)O(2)-producing microbe showing low MPO binding, with high-MPO-binding Escherichia coli, Staphylococcus aureus, or Pseudomonas aeruginosa without exogenous H(2)O(2), with and without MPO, and with and without erythrocytes (red blood cells [RBCs]). Selectivity of MPO microbicidal action was conventionally measured as the MPO MIC and minimal bactericidal concentration (MBC) for 82 bacteria including E. coli, P. aeruginosa, S. aureus, Enterococcus faecalis, Streptococcus pyogenes, Streptococcus agalactiae, and viridans streptococci. Both H(2)O(2) and OCl(-) destroyed RBCs at submicrobicidal concentrations. Nanomolar concentrations of MPO increased H(2)O(2) microbicidal action 1,000-fold. Streptococci plus MPO produced potent synergistic microbicidal action against all microbes tested, and RBCs caused only a small decrease in potency without erythrocyte damage. MPO directly killed H(2)O(2)-producing S. pyogenes but was ineffective against non-H(2)O(2)-producing E. faecalis. The MPO MICs and MBCs for E. coli, P. aeruginosa, and S. aureus were significantly lower than those for E. faecalis. The streptococcal studies showed much higher MIC/MBC results, but such testing required lysed horse blood-supplemented medium, thus preventing valid comparison of these results to those for the other microbes. E. faecalis MPO binding is reportedly weak compared to binding of E. coli, P. aeruginosa, and S. aureus but strong compared to binding of streptococci. Selective MPO binding results in selective killing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974824      PMCID: PMC3019908          DOI: 10.1128/IAI.00910-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Halide dependence of the myeloperoxidase-mediated antimicrobial system of the polymorphonuclear leukocyte in the phenomenon of electronic excitation.

Authors:  R C Allen
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

2.  The Streptococcus faecalis oxidases for reduced diphosphopyridine nucleotide. III. Isolation and properties of a flavin peroxidase for reduced diphosphopyridine nucleotide.

Authors:  M I DOLIN
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

3.  Influence of pH and temperature on the survival of coliforms and enteric pathogens when exposed to chloramine.

Authors:  C T BUTTERFIELD; E WATTIE
Journal:  Public Health Rep       Date:  1946-02-08       Impact factor: 2.792

4.  THE ANTISEPTIC ACTION OF HYPOCHLORITES: The Ancient History of the "New Antiseptic.".

Authors:  H D Dakin
Journal:  Br Med J       Date:  1915-12-04

5.  Studies on the Mode of Action of Compounds Containing Available Chlorine.

Authors:  H C Marks; O Wyss; F B Strandskov
Journal:  J Bacteriol       Date:  1945-03       Impact factor: 3.490

6.  Lifetime and diffusion of singlet oxygen in a cell.

Authors:  Esben Skovsen; John W Snyder; John D C Lambert; Peter R Ogilby
Journal:  J Phys Chem B       Date:  2005-05-12       Impact factor: 2.991

7.  Prevention of bacterial overgrowth.

Authors:  K Sprunt; G A Leidy; W Redman
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

8.  Reduced-oxidized difference spectral analysis and chemiluminescence-based Scatchard analysis demonstrate selective binding of myeloperoxidase to microbes.

Authors:  Robert C Allen; Jackson T Stephens
Journal:  Luminescence       Date:  2010-03-30       Impact factor: 2.464

9.  Hydrogen peroxide excretion by oral streptococci and effect of lactoperoxidase-thiocyanate-hydrogen peroxide.

Authors:  J Carlsson; Y Iwami; T Yamada
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Evaluation of the capacity of oral streptococci to produce hydrogen peroxide.

Authors:  A García-Mendoza; J Liébana; A M Castillo; A de la Higuera; G Piédrola
Journal:  J Med Microbiol       Date:  1993-12       Impact factor: 2.472

View more
  33 in total

1.  In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.

Authors:  G A Denys; J C Davis; P D O'Hanley; J T Stephens
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Protective role of D-amino acid oxidase against Staphylococcus aureus infection.

Authors:  Hideaki Nakamura; Jun Fang; Hiroshi Maeda
Journal:  Infect Immun       Date:  2012-01-23       Impact factor: 3.441

Review 3.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

4.  Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.

Authors:  Gerald A Denys; Chris M Pillar; Daniel F Sahm; Peter O'Hanley; Jackson T Stephens
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

5.  Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection.

Authors:  Wiebke Theeß; Julie Sellau; Christiane Steeg; Anna Klinke; Stephan Baldus; Jakob P Cramer; Thomas Jacobs
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

6.  Microbicidal activity of vascular peroxidase 1 in human plasma via generation of hypochlorous acid.

Authors:  Hong Li; Zehong Cao; D Ray Moore; Patricia L Jackson; Stephen Barnes; J David Lambeth; Victor J Thannickal; Guangjie Cheng
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

Review 7.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

8.  Human urinary exosomes as innate immune effectors.

Authors:  Thomas F Hiemstra; Philip D Charles; Tannia Gracia; Svenja S Hester; Laurent Gatto; Rafia Al-Lamki; R Andres Floto; Ya Su; Jeremy N Skepper; Kathryn S Lilley; Fiona E Karet Frankl
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

9.  Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe.

Authors:  Ethan K Gough; Claire D Bourke; Chipo Berejena; Annie Shonhai; Mutsa Bwakura-Dangarembizi; Andrew J Prendergast; Amee R Manges
Journal:  Gut Microbes       Date:  2020-02-05

Review 10.  Staphylococcal response to oxidative stress.

Authors:  Rosmarie Gaupp; Nagender Ledala; Greg A Somerville
Journal:  Front Cell Infect Microbiol       Date:  2012-03-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.